NIH-funded research NIH-funded research

Kansas PKD Translational Resource Core Center for Patient-Focused PKD research

Official title: Kansas PKD Research and Translation Core Center

Funded at University of Kansas Medical Center · NIH-11420603 · Data updated 2026-11-12

This grant supports a center that provides human kidney biospecimens, primary cells, and in vitro PKD assays to researchers investigating adult polycystic kidney disease (ADPKD).

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startJuly 15, 2020
Project endAugust 31, 2030
Funding year2026
Award (this year)$585,540
NIH project number5U54DK126126-07
Project IDNIH-11420603 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals with or at risk for ADPKD, including young patients enrolled in the EPOC cohort, their siblings, and normal volunteers linked to biospecimens.

Less likely to help

This resource may have limited direct benefit for patients not involved in PKD research or who are not in the cohort; benefits mainly accrue through research advancement.

What this research studies

If you have ADPKD or are at risk, this center helps by supplying high-quality biospecimens and cell-based tools to researchers studying the disease. It maintains the EPOC multi-center cohort of young people with early ADPKD, undiagnosed individuals, and controls linked to biospecimens. The center also runs educational programs for students and engages patients through a participation group to keep research patient-centered. By expanding biospecimen resources and translational assays, it aims to accelerate discoveries that could translate into better care for PKD patients. Researchers collaborate with the Kansas RTCC to advance PKD science and develop new treatments.

Why it matters

Potential benefit: If successful, patients with PKD could see faster development of therapies and better understanding of disease mechanisms.

How similar studies have gone: Previous PKD resource cores have enabled translational studies by providing biospecimens and assays, showing the value of such infrastructure.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Wallace, Darren P. — University of Kansas Medical Center
  • Study coordinator: Wallace, Darren P.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.